Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2015 Jul 14;3(7):e12436. doi: 10.14814/phy2.12436

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2015 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of the American Physiological Society and The Physiological Society.

This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Effects of 2 months of chronic treatment with luseogliflozin, lisinopril, combination therapy and insulin on glomerular injury score (A), percentage of severe glomerulosclerosis (B) and renal cortical fibrosis (C) in Dahl-STZ rats. Numbers in parenthesis indicate the number of rats, glomeruli and areas in which a complete data set was collected per group. ^#Indicates a significant difference from the corresponding values in the baseline control group of Dahl salt-sensitive rats. *Indicates a significant difference from the corresponding value in vehicle-treated rats. ^†Indicates a significant difference from the corresponding value in luseogliflozin-treated rats.